TIVA versus Inhalation
PreclinicalSmall molecule
TIVA versus Inhalation is one of 4 small molecule programs targeting Total Intravenous Anesthesia. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
12 competitors in Total Intravenous Anesthesia
#DrugCompanyPhaseTrials
1Anerem
AAcacia Pharma Ltd
Approved
Ondexxya
UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
Preclinical
Ciprofol
Haisco Pharmaceutical Group Co., Ltd.Preclinical
TIVA versus Inhalation
JJagiellonian University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for TIVA versus Inhalation. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- JJagiellonian University